Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan

BACKGROUND: There is limited evidence that rituximab, a B cell depletion therapy, is an effective treatment for systemic lupus erythematosus (SLE). Data on the mechanisms of B cell depletion in SLE indicate that the combination of rituximab and belimumab may be more effective than rituximab alone. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Muller, Patrick, Chowdhury, Kashfia, Gordon, Caroline, Ehrenstein, Michael R., Doré, Caroline J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364494/
https://www.ncbi.nlm.nih.gov/pubmed/32677992
http://dx.doi.org/10.1186/s13063-020-04391-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364494/
https://www.ncbi.nlm.nih.gov/pubmed/32677992
http://dx.doi.org/10.1186/s13063-020-04391-2

Ejemplares similares